References
- Carstensen J. T., Rhodes C. T. Pellicle formation in gelatin capsules. Drug Dev. Ind. Pharm. 1993; 19(20)2709–2712
- Murthy K. S., Enders N. A., Fawzi M. B. Dissolution stability of hard-shell capsule products, part 1: The effect of exaggerated storage conditions. Pharm. Technol. 1989; 13(3)72–85
- Chafetz L., Phillip J. Decrease in the rate of capsule dissolution due to formaldehyde from polysorbate 80. J. Pharm. Sci. 1984; 73(8)1186–1187
- JCooper W., Jr., Ansel H. C., Cadwallader D. E. Liquid and solid interactions of primary certified colorants with pharmaceutical gelatins. J. Pharm. Sci. 1973; 62(7)1156–1164
- Jones B. E. Hard gelatin capsules, Manuf. Chem. Aerosol News 1969, February
- Digenis G. A., Gold T. B., Shah V. P. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivoperformance. J. Pharm. Sci. 1994; 83(7)915–921
- Marks C. A., Tourtellotte E., Andux A. The phenomenon of gelatin insolubility. Food Technol. 1968; 22: 1433
- Dey M., Enever R., Kramt M., Prue D., Smith D., Weierstall R. The dissolution and bioavailability of Etodolac from capsules exposed to condition of high relative humidity and temperature. Pharm. Res. 1993; 10(9)1295–1300
- Murthy K. S., Reisch R. G., Jr., Fawzi M. B. Dissolution stability of hard-shell capsule products, part II: The effect of dissolution test conditions on in vitrodrug release. Pharm. Technol. 1989; 13(6)53–58
- Dahl T. C., Sue L. T., Yum A. The effect of pan-creatin on the dissolution performance of gelatin-coated tablets exposed to high-humidity condition. Pharm. Res. 1991; 8(3)412–414
- Florey K. Analytical Profile of Drug Substances. Academic Press, Inc., New York 1981; Vol. 10: 405–441